NovoCure Limited (NVCR)
USD 31.54
(-1.73%)
USD 31.54
(-1.73%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 509.33 Million | 537.84 Million | 535.03 Million | 494.36 Million | 351.31 Million | 248.06 Million |
| Cost of Revenue | 128.28 Million | 114.86 Million | 114.87 Million | 106.5 Million | 88.6 Million | 80.04 Million |
| Gross Profit | 381.05 Million | 422.97 Million | 420.15 Million | 387.86 Million | 262.71 Million | 168.02 Million |
| Operating Expenses | 613.92 Million | 512.49 Million | 464.48 Million | 357.46 Million | 263.62 Million | 201.69 Million |
| Selling, General and Administrative Expenses | 390.86 Million | 306.41 Million | 263.18 Million | 225.45 Million | 184.62 Million | 151.11 Million |
| Research and Development Expenses | 223.06 Million | 206.08 Million | 201.3 Million | 132.01 Million | 79 Million | 50.57 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 742.2 Million | 627.36 Million | 579.36 Million | 463.96 Million | 352.23 Million | 281.74 Million |
| Operating Income | -232.87 Million | -89.52 Million | -44.33 Million | 21.25 Million | -914 Thousand | -33.67 Million |
| Interest Expense | 4.1 Million | 3.33 Million | 3.44 Million | 13.14 Million | 13.71 Million | 13.49 Million |
| Income Tax Expense | 15.3 Million | 10.68 Million | 6.27 Million | -1.7 Million | -1.59 Million | 17.61 Million |
| Earnings before Tax | -191.74 Million | -81.84 Million | -52.07 Million | 18.1 Million | -8.82 Million | -45.94 Million |
| Net Income | -207.04 Million | -92.53 Million | -58.35 Million | 19.8 Million | -7.23 Million | -63.55 Million |
| Earnings Per Share Basic | -1.95 | -0.88 | -0.56 | 0.20 | -0.07 | -0.69 |
| Earnings Per Share Diluted | -1.95 | -0.88 | -0.56 | 0.18 | -0.07 | -0.69 |
| Weighted Average Shares Outstanding | 106.39 Million | 104.66 Million | 103.43 Million | 100.93 Million | 97.23 Million | 91.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 106.39 Million | 104.66 Million | 103.43 Million | 108.87 Million | 97.23 Million | 91.82 Million |
| Gross Margin | 0.75 | 0.79 | 0.79 | 0.78 | 0.75 | 0.68 |
| EBIT Margin | -0.35 | -0.17 | -0.08 | 0.06 | -0.00 | -0.14 |
| Profit Margin | -0.41 | -0.17 | -0.11 | 0.04 | -0.02 | -0.26 |
| EBITDA | -175.86 Million | -63.1 Million | -38.38 Million | 45.3 Million | 14.21 Million | -23.44 Million |
| Earnings Before Tax Margin | -0.46 | -0.17 | -0.08 | 0.04 | -0.00 | -0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 155.09 Million | 150.35 Million | 138.5 Million | 133.78 Million | 509.33 Million | 127.32 Million |
| Cost of Revenue | 35.37 Million | 34.65 Million | 33.68 Million | 32.55 Million | 128.28 Million | 32.09 Million |
| Gross Profit | 119.72 Million | 115.7 Million | 104.81 Million | 101.22 Million | 381.05 Million | 95.22 Million |
| Operating Expenses | 151.81 Million | 149.3 Million | 146.33 Million | 152.94 Million | 613.92 Million | 153.47 Million |
| Selling, General and Administrative Expenses | 99.93 Million | 94.35 Million | 94.73 Million | 98.63 Million | - | 99.85 Million |
| Research and Development Expenses | 51.88 Million | 54.95 Million | 51.59 Million | 54.3 Million | - | 53.62 Million |
| Other Expenses | - | -27 Thousand | - | - | - | - |
| Cost and Expenses | 187.18 Million | 183.96 Million | 180.02 Million | 185.5 Million | 742.2 Million | 185.56 Million |
| Operating Income | -32.09 Million | -33.6 Million | -41.52 Million | -51.71 Million | -232.87 Million | -58.24 Million |
| Interest Expense | - | - | - | 9.16 Million | 3.31 Million | - |
| Income Tax Expense | 8.98 Million | 10.64 Million | 7.11 Million | 8.54 Million | 15.3 Million | 1.26 Million |
| Earnings before Tax | -21.58 Million | -22.72 Million | -31.64 Million | -38.53 Million | -191.74 Million | -48.22 Million |
| Net Income | -30.57 Million | -33.37 Million | -38.76 Million | -47.07 Million | -207.04 Million | -49.48 Million |
| Earnings Per Share Basic | -0.28 | -0.31 | -0.36 | -0.44 | - | -0.46 |
| Earnings Per Share Diluted | -0.28 | -0.31 | -0.36 | -0.44 | - | -0.46 |
| Weighted Average Shares Outstanding | 108.24 Million | 107.7 Million | 107.26 Million | 106.98 Million | 106.39 Million | 106.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 108.24 Million | 107.7 Million | 107.26 Million | 106.98 Million | 106.39 Million | 106.77 Million |
| Gross Margin | 0.77 | 0.77 | 0.76 | 0.76 | 0.75 | 0.75 |
| EBIT Margin | -0.19 | -0.20 | -0.28 | -0.03 | - | -0.44 |
| Profit Margin | -0.20 | -0.22 | -0.28 | -0.35 | -0.41 | -0.39 |
| EBITDA | -29.63 Million | -30.74 Million | -38.7 Million | -4.54 Million | - | -55.44 Million |
| Earnings Before Tax Margin | -0.21 | -0.22 | -0.30 | -0.39 | -0.46 | -0.46 |
ATHJF
WLDS
JIN
DMP
OPRX
APE